Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) variants and breast cancer risk in Burkina Faso.

Kiendrebeogo IT, Zoure AA, Sorgho PA, Yonli AT, Djigma FW, Ouattara AK, Sombie HK, Tovo SF, Yelemkoure ET, Bambara AH, Sawadogo AY, Bakri Y, Simpore J. Biomol Concepts. 2019 Nov 9 ;10(1):175-183. doi : 10.1515/bmc-2019-0020. PMID : 31707358
https://www.ncbi.nlm.nih.gov/pubmed/31707358

Abstract
Background and objective Breast cancer remains the most common cause of cancer mortality in women. The aim of this study was to investigate associations between genetic variability in GSTM1 and GSTT1 and susceptibility to breast cancer. Methods Genomic DNA was extracted from blood samples for 80 cases of histologically diagnosed breast cancer and 100 control subjects. Genotyping analyses were performed by PCR-based methods. Associations between specific genotypes and the development of breast cancer were examined using logistic regression to calculate odds ratios [1] and 95% confidence intervals (95%CI). Results No correlation was found between GSTM1-null and breast cancer (OR = 1.83 ; 95%CI 0.90-3.71 ; p = 0.10), while GSTT1-null (OR = 2.42 ; 95%CI 1.17-5.02 ; p= 0.01) was associated with increased breast cancer risk. The GSTM1/GSTT1 double null was not associated with an increased risk of developing breast cancer (OR = 2.52 ; 95%CI 0.75-8.45 ; p = 0.20). Furthermore, analysis found no association between GSTM1-null (OR =1.12 ; 95%CI 0.08-15.50 ; p = 1.00) or GSTT1-null (OR = 1.71 ; 95%CI 0.13-22.51 ; p = 1.00) and the disease stage of familial breast cancer patients or sporadic breast cancer patients (GSTM1 (OR = 0.40 ; 95%CI 0.12-1.32 ; p = 0.20) and GSTT1 (OR = 1.41 ; 95%CI 0.39-5.12 ; p = 0.75)). Also, body mass index (BMI) was not associated with increased or decreased breast cancer risk in either GSTM1-null (OR = 0.60 ; 95%CI 0.21-1.68 ; p = 0.44) or GSTT1-null (OR = 0.60 ; 95%CI 0.21-1.68 ; p =0.45). Conclusion Our results suggest that only GSTT1-null is associated with increased susceptibility to breast cancer development.
KEYWORDS :Breast cancer risk ; Burkina Faso ; GSTM1-GSTT1 ; Genotypes

PMID : 31707358 ; DOI : 10.1515/bmc-2019-0020



Université Joseph KI-ZERBO : Soutenance de quatre thèses de doctorat unique (...)

Appel à candidatures pour inscription en Master de Biologie Moléculaire et de (...)

Appel à candidature pour le recrutement d’experts, animateurs d’ateliers de (...)

Code d’Ethique et de Déontologie des Enseignants-chercheurs du Burkina (...)

Copyright LaBioGene 2013 - 2014